Readers respond to Ross Gittins’ column on religion and politics, the Age series on medical misogyny, and the federal election. These are not the worst of Ella Rich's alarming symptoms that were ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended ...

It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has declined 17% over the past three months. It seems that the market might have completely ...

We estimate the company's R&D expense to increase 11.2% in 2025. Globus Medical has merged its business with NuVasive. The combined global musculoskeletal company is focused on rapid innovation ...

BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in the MedTech space.

Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Commissions do not affect our editors' opinions or evaluations. Major medical insurance is comprehensive health insurance that covers medical services, hospitalizations, doctor visits ...